RSV Antibody Prophylaxis Needs for Extremely Preterm Infants in Their Second RSV Season
This cohort study examines children in British Columbia, Canada, born between 2013 and 2024 to assess whether use of monoclonal antibodies for a second respiratory syncytial virus (RSV) season is warranted for extremely preterm infants.
Authors
- Alfonso Solimano
- Marina Viñeta Paramo (ORCID: https://orcid.org/0000-0003-1096-3831)
- Pascal M. Lavoie (ORCID: https://orcid.org/0000-0002-2205-0362)
- Manish Sadarangani (ORCID: https://orcid.org/0000-0002-9985-6452)
- Allison W. Watts (ORCID: https://orcid.org/0000-0001-7874-7030)
- Claire Seaton (ORCID: https://orcid.org/0000-0002-9404-165X)
- Hind Sbihi
Institutions
- University of British Columbia (CA)
- BC Centre for Disease Control (CA)
- BC Children's Hospital (CA)
Publication Details
- Journal
- JAMA Pediatrics
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1001/jamapediatrics.2026.0035
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00